Methylphenidate Hydrochloride Extended-Release 36 mg/1 (Methylphenidate Hydrochloride TABLET, EXTENDED RELEASE) 36 mg/1

Methylphenidate Hydrochloride Extended-Release 36 mg/1 is a medication used to manage certain conditions. This extended-release tablet is designed for oral administration and is manufactured by SpecGx LLC in the USA.

Strength

36 mg/1

Pack Size

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-0136-01)

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methylphenidate Hydrochloride Extended-Release 36 mg/1 is commonly used for conditions that require sustained attention and focus. It is often prescribed to help manage symptoms associated with attention deficit hyperactivity disorder (ADHD). The extended-release formulation is designed to provide a prolonged effect, which can help maintain consistent levels of the medication in the body throughout the day.

Side Effects

Methylphenidate Hydrochloride Extended-Release 36 mg/1 may cause various effects, including increased alertness and concentration. Some users may experience side effects such as decreased appetite, insomnia, or mild gastrointestinal discomfort. The extended-release formulation is designed to minimize fluctuations in drug levels, which can help reduce the severity of side effects.

Precautions & Warnings

It is important to handle Methylphenidate Hydrochloride Extended-Release 36 mg/1 with care. This medication should be stored at room temperature and kept out of reach of children. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the extended-release tablets, as this can alter the drug's release mechanism.

Avoid Interactions

Methylphenidate Hydrochloride Extended-Release 36 mg/1 may interact with certain substances, including alcohol and other stimulants. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions. Some medications, such as monoamine oxidase inhibitors (MAOIs), can have serious interactions with methylphenidate and should be avoided.

Frequently Asked Questions

Methylphenidate Hydrochloride Extended-Release 36 mg/1 is primarily used to manage symptoms of attention deficit hyperactivity disorder (ADHD).

This medication is designed for oral administration and should be taken as directed by a healthcare professional. Do not crush or chew the extended-release tablets.

Common side effects may include decreased appetite, insomnia, and mild gastrointestinal discomfort. Always consult a healthcare provider for personalized advice.

It is generally advised to avoid alcohol while taking Methylphenidate Hydrochloride Extended-Release 36 mg/1, as it may increase the risk of side effects.

If you miss a dose, consult your healthcare provider for guidance. Do not double the dose to make up for a missed one.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.